-

Medisca Opens New Pharmaceutical Repackaging Facility to Meet Global Demands in Personalized Medicine

PLATTSBURGH, N.Y.--(BUSINESS WIRE)--Medisca, a global leader in personalized pharmaceutical solutions, held a grand opening event on June 20, 2024, for their new repackaging and distribution facility in Plattsburgh, New York. The event was celebrated in the company of Medisca’s valued Plattsburgh team, business partners, and state and federal officials, including Congresswoman Elise Stefanik, Senator Dan Stec, and Assemblyman Billy Jones.

"This event marks the completion of the largest project ever undertaken by Medisca in our 35-year history," said Antonio Dos Santos, Medisca Founder and Chairman. “This new facility showcases the diligent efforts and dedication of Medisca people and demonstrates our commitment to supporting the growing demands in personalized medicine."

Continued investment in the North Country

After 32 years of established standing and investment in the North Country, the opening of the new Medisca facility in Plattsburgh exemplifies the value of the workforce in this region.

"The new Medisca facility is a testament to our local workforce talent pool, already providing 65 good-paying local jobs with plans for further expansion," said Congresswoman Elise Stefanik. "This significant investment in Plattsburgh underscores the strength of our region. I am proud to support Medisca and the many industries investing in our community and driving economic prosperity for hardworking families in Upstate and the North Country."

Doubling capacity to serve the growing demands in personalized medicine

Consolidating existing operations into a single site equipped with innovative machinery and automated workflows, the new facility will significantly enhance the company’s capacity to support the diverse healthcare groups it serves.

“In particular, the new facility will allow Medisca to expand its capacity to provide quality products to pharmacists and healthcare professionals, so they can prepare personalized and essential medications for patients like you and me – not just here in the United States, but across the globe,” said Sanjay Goorachurn, Medisca CEO.

Leveraging scalable innovation, reinforcing established quality systems, and prioritizing the health, safety, and wellness of Medisca personnel were paramount in every decision made during the design and construction of the new facility. Key considerations included introducing custom-tailored ISO-rated production rooms and leveraging customized warehouse management systems for end-to-end traceability.

“Taken together, the new facility is a state-of-the-art example that leverages innovation and rigorous quality and safety measures to protect our product, personnel, and environment,” said Dos Santos.

The new Medisca Plattsburgh facility has undergone a successful New York State inspection and third-party documentation and systems audit, with additional licensures and agency inspections actively underway to serve the United States and Global markets. For a look at the new facility, click here.

About Medisca

Founded in 1989, Medisca is a global leader in personalized medicine and pharmaceutical supply chain solutions. Its vast portfolio of over 2,000 products is complemented by a library of 10,000+ proprietary and customized medication formulas, expertise, and services in pharmaceutical compounding, continuing healthcare education, analytical testing, and more. Providing finely-tuned solutions to diverse wellness sectors across the globe, Medisca is bridging the gaps in healthcare and empowering personalized wellness for all. For more information, visit www.medisca.com and follow us on LinkedIn, Facebook, and YouTube.

Contacts

Medisca Communications
communications@medisca.com
1-800-665-6334

More News From Medisca

Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos

MONTREAL--(BUSINESS WIRE)--For more than 35 years, Dos Santos has helped shape Medisca into a global leader in pharmaceutical compounding. As Chief Executive Officer, he will lead the company's long-term strategy, with a focus on expanding Medisca's global reach, investing in new areas of growth, strengthening strategic partnerships, and continuing to advance the products, services, education, and expertise that healthcare professionals rely on every day. "When I founded Medisca, my vision was...

Medisca and dsm–firmenich Partner to Expand Access to Pharmaceutical-Grade Vitamin APIs for U.S. Compounding Market

MONTREAL--(BUSINESS WIRE)--Medisca, a global leader in personalized pharmaceutical medicine, has entered into a strategic partnership with dsm–firmenich, a leading ingredient manufacturer serving regulated pharmaceutical markets worldwide. Through this partnership, Medisca will make a portfolio of pharmaceutical-grade vitamin active pharmaceutical ingredients (APIs) available to U.S. compounding professionals, expanding access to ingredients manufactured within European cGMP environments and su...

Medisca Secures Settlement With FlackTek, Reinforcing Patent Strength of MAZ® Mixer

PLATTSBURGH, N.Y.--(BUSINESS WIRE)--Medisca and FlackTek have reached a settlement to resolve their patent dispute relating to the Medisca MAZ® mixer and related mixing technologies set forth in Medisca U.S. patent numbers 10,420,705, 10,765,600, 11,090,224, 11,096,864, 10,231,903, and 10,993,876. The confidential settlement resolves the pending litigation. “This settlement validates the investment Medisca has made over the past decade in the MAZ innovation and technology,” said Sanjay Goorachu...
Back to Newsroom